GROUP ONE TRADING, L.P. - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is and the CUSIP is 91911K902. A total of 4 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$12,982,000
-31.8%
558,600
-53.3%
0.11%
-42.2%
Q1 2018$19,037,000
-51.7%
1,195,800
-36.9%
0.19%
-30.7%
Q4 2017$39,380,000
+478.1%
1,895,100
+298.6%
0.28%
+346.8%
Q3 2017$6,812,000
-53.1%
475,400
-43.3%
0.06%
-58.9%
Q2 2017$14,513,000
+205.7%
838,900
+94.9%
0.15%
+174.5%
Q1 2017$4,747,000
-83.5%
430,400
-78.3%
0.06%
-80.3%
Q4 2016$28,739,000
-31.1%
1,979,300
+16.5%
0.28%
-38.4%
Q3 2016$41,710,000
+37.8%
1,699,000
+13.0%
0.45%
+26.5%
Q2 2016$30,276,000
-25.7%
1,503,300
-2.9%
0.36%
-37.7%
Q1 2016$40,736,000
-73.0%
1,548,900
+4.3%
0.58%
-67.8%
Q4 2015$150,971,000
+141.5%
1,485,200
+323.9%
1.78%
+106.5%
Q3 2015$62,504,000
+166.4%
350,400
+231.8%
0.86%
+163.4%
Q2 2015$23,459,000
-33.0%
105,600
-40.1%
0.33%
-40.3%
Q1 2015$34,997,000
+26.5%
176,200
-8.8%
0.55%
+31.3%
Q4 2014$27,663,000
+30.0%
193,300
+19.2%
0.42%
+27.4%
Q3 2014$21,281,000
+65.4%
162,200
+59.0%
0.33%
+65.7%
Q2 2014$12,864,000
+66.8%
102,000
+74.4%
0.20%
+52.3%
Q1 2014$7,712,000
-47.7%
58,500
-53.5%
0.13%
-41.7%
Q4 2013$14,757,000
+13.0%
125,700
+0.4%
0.22%
-10.8%
Q3 2013$13,062,000
+19.1%
125,200
-1.7%
0.25%
-7.4%
Q2 2013$10,967,000127,4000.27%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q4 2013
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 360,000$8,838,0002.84%
GLENHILL ADVISORS LLC 38,075$9,872,0000.59%
FARLEY CAPITAL L.P. 17,000$417,0000.55%
GROUP ONE TRADING, L.P. 1,699,000$41,710,0000.45%
Birch Grove Capital LP 20,000$145,0000.14%
CMT Asset Management Ltd 50,300$1,235,0000.06%
Pentwater Capital Management LP 220,000$5,401,0000.05%
SIMPLEX TRADING, LLC 8,586$625,0000.04%
Timber Hill LLC 122,200$3,000,0000.01%
JPMORGAN CHASE & CO 580,000$14,239,0000.00%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders